WeVote

Bill

Bill

S 4123

Requires involuntary commitment of certain individuals who have been administered opioid antidotes.

2026-2027 Regular Session Introduced by Kristin Corrado

Allows involuntary commitment for certain overdose patients treated with antidotes to pursue treatment and prevent repeat incidents.

0
WeVote Research Nonpartisan
Bill Summary · S 4123

Summary: S 4123 (New Jersey, Session 222)

Overview

  • Jurisdiction: New Jersey
  • Bill Title: Requires involuntary commitment of certain individuals who have been administered opioid antidotes
  • Senate Bill: S 4123
  • Co-sponsor: Kristin Corrado

This bill addresses circumstances in which individuals who have received opioid overdose reversal medication (most commonly naloxone) may be subject to involuntary commitment proceedings. The measure sets rules for temporary or longer-term treatment based on specific criteria following administration of opioid antidotes.

Purpose and Intent

  • To provide a framework for involuntary commitment (civil commitment) for individuals who have suffered opioid overdoses and were treated with an opioid antidote.
  • The underlying aim is to intervene for persons at risk of repeated overdoses or ongoing substance use disorder, with the goal of facilitating access to treatment and preventing future harm or death.

Key Provisions (Summary of Changes)

  • Trigger for Commitment: The bill designates certain conditions under which an individual who has been administered an opioid antidote may be subject to involuntary commitment proceedings. The specific criteria typically involve:

    • A recent opioid overdose reversal with naloxone (or other approved antidote).
    • An assessment by qualified professionals indicating risk of imminent danger to self or others due to substance use.
    • Presence of a diagnosable substance use disorder (SUD) and inability or unwillingness to engage in voluntary treatment.
  • Types of Commitment: The bill outlines the process for:

    • Temporary or emergency involuntary commitment (usually short-term, for stabilization).
    • Extended or longer-term involuntary commitment (subject to court review and periodic reevaluation).
  • Evaluation and Protections: Requirements may include:

    • Medical and psychiatric examinations to determine mental health and treatment needs.
    • Regular court hearings and the opportunity for the person to contest the commitment.
    • Safety and rights protections consistent with existing civil commitment statutes (e.g., least restrictive alternative, periodic reviews, due process).
  • Treatment Standards: Provisions are expected to specify that individuals receive appropriate treatment for substance use disorders, including addiction treatment services, detoxification if needed, and placement in appropriate treatment facilities or programs.

  • Roles and Responsibilities: Designates the responsibilities of:

    • Law enforcement and medical personnel in identifying candidates for commitment.
    • Mental health and addiction treatment authorities to evaluate and manage commitment cases.
    • Courts in approving, reviewing, and terminating involuntary commitments.
  • Duration and Review: Timelines for commitment duration, mandatory periodic reviews, and criteria for discharge or transition to voluntary treatment.

  • Privacy and Compliance: Adheres to existing confidentiality and privacy requirements for individuals’ health and treatment information.

Who Would Be Affected

  • Individuals who experience opioid overdoses and are treated with opioid antidotes (e.g., naloxone) and who meet the statutory criteria for commitment.
  • Family members and caregivers who seek intervention under the new framework.
  • Medical, emergency, and law enforcement personnel involved in overdose responses and in identifying candidates for commitment.
  • Mental health, substance use treatment providers, and courts involved in evaluation, treatment placement, and ongoing supervision of committed individuals.

Procedural and Timeline Aspects

  • The bill would establish:
    • Qualification steps for initiating involuntary commitment.
    • Required assessments or evaluations by qualified professionals.
    • A sequence of court approvals and hearings (timelines to be specified by statute) to authorize and renew commitments.
    • Regular review intervals to determine ongoing need for commitment or discharge.
    • Procedures to ensure compliance with civil rights and due process protections.

Potential Impacts and Considerations

  • Public Health Impact: Aims to reduce repeat overdoses by linking overdose reversals to treatment entry.
  • System Burden: Could increase involvement of courts, mental health professionals, and treatment facilities in overdose cases.
  • Balance of Interests: Requires careful application to protect individual civil liberties while addressing safety concerns and treatment needs.
  • Funding and Resources: Implementation would likely require allocations for assessment, housing or treatment bed capacity, and staff training.

Notes

  • This summary reflects the bill’s stated aim and provisions as described. For exact statutory language, specific criteria, thresholds, and procedural steps, consult the full text of S 4123 and any amendments adopted during the legislative process.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.